Skip to main content
. Author manuscript; available in PMC: 2024 Oct 13.
Published in final edited form as: Vaccine. 2023 Sep 14;41(43):6461–6469. doi: 10.1016/j.vaccine.2023.08.071

Figure 4. Average genotypic SPVL under a 1log10 vaccine campaign with varying coverage levels.

Figure 4.

Points represent the mean genotypic SPVL at the time point indicated, showing a no-vaccine scenario and varying coverage levels of a vaccine that reduces phenotypic SPVL by 1.0 log10 copies/ml, over fifty replicates. Bars represent the 95% confidence interval.